In the BioHarmony Drug Report Database

"Preview" Icon

Bedaquiline

Sirturo (bedaquiline) is a small molecule pharmaceutical. Bedaquiline was first approved as Sirturo on 2012-12-28. It is used to treat multidrug-resistant tuberculosis and mycobacterium infections in the USA. It has been approved in Europe to treat multidrug-resistant tuberculosis. Sirturo’s patent is valid until 2029-03-19 (FDA).

 

Trade Name

 

Sirturo
 

Common Name

 

bedaquiline
 

ChEMBL ID

 

CHEMBL376488
 

Indication

 

multidrug-resistant tuberculosis, mycobacterium infections
 

Drug Class

 

Antibiotics, diarylquinoline structure

Image (chem structure or protein)

Bedaquiline structure rendering